[1] 强晖.基因芯片技术及其在肝脏疾病中的应用研究进展[J].国外医学:消化系疾病分册,2003,23(1):29-32. [2] 周学平,王红阳,杨广顺,等.MXR7基因的克隆及其在人正常和肿瘤组织中的表达[J].中华实验外科杂志,1999,16(2):144-146. [3] 方宁波,李勇. MXR7基因与原发性肝癌关系的研究进展[J]. 南昌大学学报(医学版),2013,53(5):97-100. [4] 汪胜豪,Muhammad Kalim,詹金彪.GPC3的结构和功能及其在肝细胞癌诊治中的应用[J].中国细胞生物学报,2018,40(2):1-7. [5] Lage H,Dietel M.Cloning and characterization of human cDNAs encoding a protein with high homology to rat intestinal development protein OCI-5[J].Gene,1997,188(2):151-156. [6] LI Youcai, YANG Chuansheng, ZHOU Wenlan, et al.Low glucose metabolism in hepatocellular carcinoma with GPC3 expression[J]. World J Gastroenterol,2018,24(4):494-503. [7] LV Guishuai, TANG Yexiong, LV Hongwei,et al.MXR7 facilitates liver cancer metastasis via epithelial-mesenchymal transition[J]. Science China Life Sciences,2017,60(11):1-11. [8] Bertino G,Ardiri A,Malaguarnera M,et al. Cancer statistics,2012[J]. CA Cancer J Clin,2012,39(4):410-433. [9] SUN Bin, HUANG Zhi, WANG Bi, et al.Significance of glypican-3 (GPC3) expression in hepatocellular cancer diagnosis[J]. Med Sci Monit, 2017,23: 850-855. [10] Tremosini S,Forner A,Boix L,et al. Prospective validation of an immunohistochemical panel(glypican 3,heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma[J]. Gut,2012,61(10):1 481-1 487. [11] Masuzaki R, Karp S J, Omata M. New serum markers of hepatocellular carcinoma[J]. Semin Oncol,2012,39(4):434-439. |